The following are today's upgrades for Validea's Contrarian Investor model based on the published strategy of David Dreman. This contrarian strategy finds the most unpopular mid- and large-cap stocks in the market and looks for improving fundamentals.
The following are today's upgrades for Validea's Small-Cap Growth Investor model based on the published strategy of Motley Fool. This strategy looks for small cap growth stocks with solid fundamentals and strong price performance.
The following are today's upgrades for Validea's Book/Market Investor model based on the published strategy of Joseph Piotroski. This value-quant strategy screens for high book-to-market stocks, and then separates out financially sound firms by looking at a host of improving f
The following are today's upgrades for Validea's Price/Sales Investor model based on the published strategy of Kenneth Fisher. This value strategy rewards stocks with low P/S ratios, long-term profit growth, strong free cash flow and consistent profit margins.
The following are today's upgrades for Validea's Earnings Yield Investor model based on the published strategy of Joel Greenblatt. This value model looks for companies with high return on capital and earnings yields.
Somewhere on your company's HR website, you'll find a 401(k) plan document (or similar) that outlines the rules and regulations behind your firm's retirement structure. While it's common knowledge that no employee has ever read these documents from end to end -- other than those
What happened
Peloton Interactive (NASDAQ: PTON) stock rocketed 29.4% in September, according to data from S&P Global Market Intelligence. For context, the S&P 500 and Nasdaq indexes fell 3.8% and 5.2%, respectively, last month.
There's a reason so many seniors wind up claiming Social Security at 62: It's the earliest age to file for benefits. But there's a downside to signing up for Social Security that young. Doing so will slash your monthly benefit for life.
As expected, Tesla (NASDAQ: TSLA) reported a record number of vehicle deliveries in its third quarter. The total number of deliveries, however, was even greater than analysts' average forecast. Fueling the quarter's growth was a huge increase in combined Model 3 and Model Y vehi
Usually, people don't bust out the scary stuff until October, but in the stock market, it was late September that spooked investors, sending stocks on a screaming decline. But while other investors are running from the tricks this month, you should be on the lookout for treats i
With October comes long-awaited third-quarter earnings. And after an eventful summer dominated by the coronavirus pandemic, those results will reveal how companies have fared during these challenging times and how their futures are affected.
There's some good news during the coronavirus pandemic: A recent survey by Schwab indicates the average amount 401(k) plan participants contributed to their accounts this year is up 20% compared with last year.
Apple is a phenomenal company by just about every measure. But with a market capitalization around $2 trillion, it's massive size makes it less appealing to investors who are looking to put their money into companies with long runways for growth.
While many investors like to talk about diversity in their portfolios, perhaps not enough attention gets paid to diversity within individual businesses. That's too bad; large businesses with multiple product lines are often safer, since if one business struggles, another segment
Boston Omaha (NASDAQ: BOMN) hasn't exactly been a standout this year. Even after a recent rebound, the young holding company's stock price is more than 21% lower than where it started 2020, dramatically underperforming the 5% gain in the S&P 500.
Vertex Pharmaceuticals (NASDAQ: VRTX) is the blueprint for a growing pharmaceutical stock. Since it went public in 1991, the company has consistently increased revenue, recording annual revenue gains the past six consecutive years.
2020 has brought a seemingly unending string of twists and turns, and the associated uncertainty has resulted in an unparalleled period of volatility for the stock market. There's a good chance that more volatility is on the way as we move into the year's final quarter, but ther
The airline industry has been battered and bruised by the COVID-19 pandemic, with travel volumes down substantially compared to last year. The airlines are all losing money right now, and with the industry not expected to make a full recovery until 2022 at the earliest carriers
Following an active September, two IPOs are scheduled to raise $200 million in the week ahead.
Several companies could join the IPO calendar early in the week, such as Spruce Biosciences (SPRB), Shattuck Labs (STTK), and Kronos Bio (KRON).
Live TV streaming platform fuboTV (FUBO
A total of 29 companies entered the public market this past week, the most ever in a single week. The week’s 11 IPOs were joined by 15 SPACs and three direct listings.
Notable new IPO filings included TPG-backed antivirus provider McAfee (MCFE), Vista Equity’s IT soft